These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10029358)

  • 1. The case for treatment of dyspeptic patients infected with H. pylori.
    Hunt RH; Huang JQ
    Eur J Surg Suppl; 1998; (582):6-10. PubMed ID: 10029358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
    Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia.
    Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A
    East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1998; 71(2):125-33. PubMed ID: 10378358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer].
    Gisbert JP
    Gastroenterol Hepatol; 2008 Oct; 31 Suppl 4():18-28. PubMed ID: 19434862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
    Sonnenberg A
    Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.
    Nakajima S; Graham DY; Hattori T; Bamba T
    Curr Pharm Des; 2000 Oct; 6(15):1503-14. PubMed ID: 10974147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health economics of Helicobacter pylori infection.
    Moayyedi P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcer and gastritis.
    Wu JC; Sung JJ
    Endoscopy; 2002 Feb; 34(2):104-10. PubMed ID: 11822005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term consequences of Helicobacter pylori eradication: clinical aspects.
    Labenz J; Tillenburg B; Peitz U; Börsch G
    Scand J Gastroenterol Suppl; 1996; 215():111-5. PubMed ID: 8722393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
    Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
    Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori: beyond peptic ulcer disease.
    Wisniewski RM; Peura DA
    Gastroenterologist; 1997 Dec; 5(4):295-305. PubMed ID: 9436005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India.
    Katelaris PH; Tippett GH; Norbu P; Lowe DG; Brennan R; Farthing MJ
    Gut; 1992 Nov; 33(11):1462-6. PubMed ID: 1452068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of H. pylori infection on the management of dyspepsia.
    Rokkas T
    Dig Dis; 2001; 19(2):123-6. PubMed ID: 11549821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
    Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
    Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication of Helicobacter pylori: therapies and clinical implications.
    O'Connor HJ
    Postgrad Med J; 1992 Jul; 68(801):549-57. PubMed ID: 1437952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.